Cargando…
Development of an Attenuated Tat Protein as a Highly-effective Agent to Specifically Activate HIV-1 Latency
Although combined antiretroviral therapy (cART) successfully decreases plasma viremia to undetectable levels, the complete eradication of human immunodeficiency virus type 1 (HIV-1) remains impractical because of the existence of a viral reservoir, mainly in resting memory CD4(+) T cells. Various cy...
Autores principales: | Geng, Guannan, Liu, Bingfeng, Chen, Cancan, Wu, Kang, Liu, Jun, Zhang, Yijun, Pan, Ting, Li, Jun, Yin, Yue, Zhang, Junsong, Huang, Feng, Yu, Fei, Chen, Jingliang, Ma, Xiancai, Zhou, Jie, Kuang, Ersheng, Liu, Chao, Cai, Weiping, Zhang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113098/ https://www.ncbi.nlm.nih.gov/pubmed/27434587 http://dx.doi.org/10.1038/mt.2016.117 |
Ejemplares similares
-
Long noncoding RNA NRON contributes to HIV-1 latency by specifically inducing tat protein degradation
por: Li, Jun, et al.
Publicado: (2016) -
HIV-1 functional cure: will the dream come true?
por: Liu, Chao, et al.
Publicado: (2015) -
TRIM28 promotes HIV-1 latency by SUMOylating CDK9 and inhibiting P-TEFb
por: Ma, Xiancai, et al.
Publicado: (2019) -
HIV latency reversing agents act through Tat post translational modifications
por: Khoury, Georges, et al.
Publicado: (2018) -
A novel HIV-1-encoded microRNA enhances its viral replication by targeting the TATA box region
por: Zhang, Yijun, et al.
Publicado: (2014)